| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Schultz S. Matthew | CEO & Chairman, Director | 10624 S. EASTERN AVE., SUITE A-638, HENDERSON | /s/ S. Matthew Schultz | 18 Feb 2026 | 0001625587 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLSK | Common Stock | Options Exercise | $0 | +20,525 | +0.88% | $0.000000 | 2,343,146 | 13 Feb 2026 | Direct | |
| transaction | CLSK | Common Stock | Options Exercise | $0 | +216,125 | +9.2% | $0.000000 | 2,559,271 | 13 Feb 2026 | Direct | |
| transaction | CLSK | Common Stock | Tax liability | $879,952 | -95,095 | -3.7% | $9.25 | 2,464,176 | 18 Feb 2026 | Direct | F1 |
| transaction | CLSK | Common Stock | Tax liability | $83,385 | -9,031 | -0.37% | $9.23 | 2,455,145 | 18 Feb 2026 | Direct | F2 |
| holding | CLSK | Common Stock | 2,322,621 | 13 Feb 2026 | Direct | ||||||
| holding | CLSK | Common Stock | 480,000 | 13 Feb 2026 | By S M Schultz Irrevocable Trust | ||||||
| holding | CLSK | Common Stock | 40,996 | 13 Feb 2026 | By Spouse | ||||||
| holding | CLSK | Series A Preferred | 500,000 | 13 Feb 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLSK | Restricted Stock Units | Options Exercise | $0 | -216,125 | -17% | $0.000000 | 1,080,625 | 13 Feb 2026 | Common Stock | 216,125 | $0.000000 | Direct | F6 |
| transaction | CLSK | Restricted Stock Units | Options Exercise | $0 | -20,525 | -13% | $0.000000 | 143,673 | 13 Feb 2026 | Common Stock | 20,525 | $0.000000 | Direct | F6 |
| holding | CLSK | Employee Stock Options (Right to Buy) | 400,000 | 13 Feb 2026 | Common Stock | 400,000 | $23.00 | Direct | F3 | |||||
| holding | CLSK | Restricted Stock Units | 627,753 | 13 Feb 2026 | Common Stock | 627,753 | $0.000000 | Direct | F4 | |||||
| holding | CLSK | Restricted Stock Units | 1,296,750 | 13 Feb 2026 | Common Stock | 1,296,750 | $0.000000 | Direct | F5 | |||||
| holding | CLSK | Restricted Stock Units | 1,729,000 | 13 Feb 2026 | Common Stock | 1,729,000 | $0.000000 | Direct | F4 | |||||
| holding | CLSK | Restricted Stock Units | 164,198 | 13 Feb 2026 | Common Stock | 164,198 | $0.000000 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | This is a weighted average of prices for sales made on February 18, 2026, ranging from $9.0901 to $9.4101. Upon request, the Reporting Person will provide to the SEC, the Issuer, or any security holder of the Issuer full information regarding the number of shares sold at each separate price. |
| F2 | This is a weighted average of prices for sales made on February 18, 2026, ranging from $9.2274 to $9.2700. Upon request, the Reporting Person will provide to the SEC, the Issuer, or any security holder of the Issuer full information regarding the number of shares sold at each separate price. |
| F3 | These Options were granted on April 16, 2021 and vested in equal monthly installments over 36 months. |
| F4 | These RSUs vest in equal annual installments over three years on September 4, 2026, September 4, 2027, and September 4, 2028. |
| F5 | These RSUs vest in equal semiannual installments over three years on February 13, 2026, September 4, 2026, February 13, 2027, September 4, 2027, February 13, 2028, and September 4, 2028. |
| F6 | These RSUs vest in equal quarterly installments on February 13, 2026, May 13, 2026, August 13, 2026, December 3, 2026, February 12, 2027, May 13, 2027, August 13, 2027, and December 3, 2027. |